Other ways to search: Events Calendar | UTHSC

Enrollment Continues in Study Evaluating ONCT-534 For Advanced Prostate Cancer


“It looks like our drug is a very strong candidate for treating these patients who have relapsed from current treatment options. It may potentially have the possibility to extend the survival,” said Ramesh Narayanan, the deputy director of the Center for Cancer Research and the Muirhead Endowed Professor in the College of Medicine at the University of Tennessee Health Science Center and one of the researchers who developed ONCT-534, in an article posted to the University of Tennessee Health Science Center’s website.

Top Publishers